These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 23717871)

  • 1. [Characterization of platelet aggregation-inducing factor podoplanin and development of its antibodies].
    Kato Y
    Seikagaku; 2013 Apr; 85(4):261-5. PubMed ID: 23717871
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.
    Kato Y; Kaneko MK; Kuno A; Uchiyama N; Amano K; Chiba Y; Hasegawa Y; Hirabayashi J; Narimatsu H; Mishima K; Osawa M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1301-7. PubMed ID: 16979138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting a novel domain in podoplanin for inhibiting platelet-mediated tumor metastasis.
    Sekiguchi T; Takemoto A; Takagi S; Takatori K; Sato S; Takami M; Fujita N
    Oncotarget; 2016 Jan; 7(4):3934-46. PubMed ID: 26684030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin.
    Oki H; Kaneko MK; Ogasawara S; Tsujimoto Y; Liu X; Sugawara M; Takakubo Y; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):174-80. PubMed ID: 26090595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies.
    Nakazawa Y; Takagi S; Sato S; Oh-hara T; Koike S; Takami M; Arai H; Fujita N
    Cancer Sci; 2011 Nov; 102(11):2051-7. PubMed ID: 21824222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract.
    Chuang WY; Chang YS; Yeh CJ; Wu YC; Hsueh C
    Histol Histopathol; 2013 Mar; 28(3):293-9. PubMed ID: 23348382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring platelet GPIIb/IIIa antagonist therapy.
    Coller BS
    Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S81-6. PubMed ID: 10070826
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor.
    Kaneko MK; Kato Y; Kameyama A; Ito H; Kuno A; Hirabayashi J; Kubota T; Amano K; Chiba Y; Hasegawa Y; Sasagawa I; Mishima K; Narimatsu H
    FEBS Lett; 2007 Jan; 581(2):331-6. PubMed ID: 17222411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2.
    Kato Y; Kaneko MK; Kunita A; Ito H; Kameyama A; Ogasawara S; Matsuura N; Hasegawa Y; Suzuki-Inoue K; Inoue O; Ozaki Y; Narimatsu H
    Cancer Sci; 2008 Jan; 99(1):54-61. PubMed ID: 17944973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
    Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
    Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2.
    Ogasawara S; Kaneko MK; Price JE; Kato Y
    Hybridoma (Larchmt); 2008 Aug; 27(4):259-67. PubMed ID: 18707544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of polypeptides derived from a snake venom C-type lectin, aggretin, on tumor cell-induced platelet aggregation.
    Chang CH; Chung CH; Hsu CC; Peng HC; Huang TF
    J Thromb Haemost; 2014 Apr; 12(4):540-9. PubMed ID: 24479713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
    Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: a study with ImageStream®.
    Ouk C; Jayat-Vignoles C; Donnard M; Feuillard J
    Cytometry A; 2011 Jun; 79(6):477-84. PubMed ID: 21462306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical detection of the lymphatic marker podoplanin in diverse types of human cancer cells using a novel antibody.
    Kono T; Shimoda M; Takahashi M; Matsumoto K; Yoshimoto T; Mizutani M; Tabata C; Okoshi K; Wada H; Kubo H
    Int J Oncol; 2007 Sep; 31(3):501-8. PubMed ID: 17671675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Antibody LpMab-9 Recognizes O-glycosylated N-Terminus of Human Podoplanin.
    Kaneko MK; Oki H; Hozumi Y; Liu X; Ogasawara S; Takagi M; Goto K; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):310-7. PubMed ID: 26492618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
    Suzuki-Inoue K
    J Biochem; 2011 Aug; 150(2):127-32. PubMed ID: 21693546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin.
    Ogasawara S; Oki H; Kaneko MK; Hozumi Y; Liu X; Honma R; Fujii Y; Nakamura T; Goto K; Takagi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Oct; 34(5):318-26. PubMed ID: 26492619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of antiphospholipid antibodies on in vitro platelet aggregation.
    Palatinus AA; Ahuja KD; Adams MJ
    Clin Appl Thromb Hemost; 2012; 18(1):59-65. PubMed ID: 21733940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of monoclonal antibody LpMab-3 recognizing sialylated glycopeptide of podoplanin.
    Oki H; Ogasawara S; Kaneko MK; Takagi M; Yamauchi M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2015 Feb; 34(1):44-50. PubMed ID: 25723283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.